CAROSPIR
Manufacturer: CMP Pharma, Inc.
Score: 141.0
CaroSpir (Spironolactone) is an aldosterone antagonist used in the management of heart failure, hypertension, and edema associated with hepatic cirrhosis. It works by blocking the effects of aldosterone, leading to increased excretion of sodium and water, and retention of potassium. The drug is available as an oral suspension and should be taken consistently with respect to food. Important safety information includes the risk of hyperkalemia, hypotension, and worsening renal function. Contraindications include hyperkalemia, Addison's disease, and concomitant use of eplerenone. Special population considerations include use in pregnancy, pediatric use, geriatric use, and patients with renal or hepatic impairment.
Risk of hyperkalemia, hypotension, and worsening renal function
Dose adjustments may be necessary in patients with renal impairment or hepatic cirrhosis
20 mg once daily, titrate as needed
20-75 mg daily, in single or divided doses
75 mg daily, in single or divided doses